We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · June 04, 2020

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome

Circulation

 

Additional Info

Circulation
Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients From 12 Randomized Trials
Circulation 2020 May 29;[EPub Ahead of Print], EP Navarese, SU Khan, M Kołodziejczak, J Kubica, S Buccheri, CP Cannon, PA Gurbel, S De Servi, A Budaj, A Bartorelli, D Trabattoni, EM Ohman, L Wallentin, MT Roe, S James

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading